168 related articles for article (PubMed ID: 27109047)
1. ETS transcription factor ERG cooperates with histone demethylase KDM4A.
Kim TD; Shin S; Janknecht R
Oncol Rep; 2016 Jun; 35(6):3679-88. PubMed ID: 27109047
[TBL] [Abstract][Full Text] [Related]
2. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
[TBL] [Abstract][Full Text] [Related]
3. Histone demethylase KDM3A is required for enhancer activation of hippo target genes in colorectal cancer.
Wang HY; Long QY; Tang SB; Xiao Q; Gao C; Zhao QY; Li QL; Ye M; Zhang L; Li LY; Wu M
Nucleic Acids Res; 2019 Mar; 47(5):2349-2364. PubMed ID: 30649550
[TBL] [Abstract][Full Text] [Related]
4. Circ_SPECC1 enhances the inhibition of miR-526b on downstream KDM4A/YAP1 pathway to regulate the growth and invasion of gastric cancer cells.
Chen LH; Wang LP; Ma XQ
Biochem Biophys Res Commun; 2019 Sep; 517(2):253-259. PubMed ID: 31349968
[TBL] [Abstract][Full Text] [Related]
5. ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors.
Nguyen LT; Tretiakova MS; Silvis MR; Lucas J; Klezovitch O; Coleman I; Bolouri H; Kutyavin VI; Morrissey C; True LD; Nelson PS; Vasioukhin V
Cancer Cell; 2015 Jun; 27(6):797-808. PubMed ID: 26058078
[TBL] [Abstract][Full Text] [Related]
6. MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A.
Mu H; Xiang L; Li S; Rao D; Wang S; Yu K
J Cell Biochem; 2019 Apr; 120(4):4987-4997. PubMed ID: 30302800
[TBL] [Abstract][Full Text] [Related]
7. Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy.
Cui SZ; Lei ZY; Guan TP; Fan LL; Li YQ; Geng XY; Fu DX; Jiang HW; Xu SH
Cancer Sci; 2020 May; 111(5):1567-1581. PubMed ID: 32133742
[TBL] [Abstract][Full Text] [Related]
8. SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation.
Tan MK; Lim HJ; Harper JW
Mol Cell Biol; 2011 Sep; 31(18):3687-99. PubMed ID: 21768309
[TBL] [Abstract][Full Text] [Related]
9. Histone demethylase KDM4A plays an oncogenic role in nasopharyngeal carcinoma by promoting cell migration and invasion.
Zhao J; Li B; Ren Y; Liang T; Wang J; Zhai S; Zhang X; Zhou P; Zhang X; Pan Y; Gao F; Zhang S; Li L; Yang Y; Deng X; Li X; Chen L; Yang D; Zheng Y
Exp Mol Med; 2021 Aug; 53(8):1207-1217. PubMed ID: 34385569
[TBL] [Abstract][Full Text] [Related]
10. Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.
Li X; Moon G; Shin S; Zhang B; Janknecht R
Mol Med Rep; 2018 Apr; 17(4):5518-5527. PubMed ID: 29393482
[TBL] [Abstract][Full Text] [Related]
11. RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.
Chen DB; Xie XW; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Fei R; Qin WY; Wang JH; Wu X; Shao QX; Wei L; Chen HS
Sci Rep; 2020 Sep; 10(1):14538. PubMed ID: 32883983
[TBL] [Abstract][Full Text] [Related]
12. The role of the histone demethylase KDM4A in cancer.
Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
[TBL] [Abstract][Full Text] [Related]
13. SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
Gu R; Kim TD; Song H; Sui Y; Shin S; Oh S; Janknecht R
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870957
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.
Oh S; Song H; Freeman WM; Shin S; Janknecht R
Int J Oncol; 2020 Dec; 57(6):1319-1332. PubMed ID: 33174020
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of PSMD10 caused by the JMJD2A histone demethylase.
Kim TD; Oh S; Lightfoot SA; Shin S; Wren JD; Janknecht R
Int J Clin Exp Med; 2016; 9(6):10123-10134. PubMed ID: 28883898
[TBL] [Abstract][Full Text] [Related]
16. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
Zhang J; Li Q; Zhang S; Xu Q; Wang T
Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
[TBL] [Abstract][Full Text] [Related]
17. Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.
Yang Y; Blee AM; Wang D; An J; Pan Y; Yan Y; Ma T; He Y; Dugdale J; Hou X; Zhang J; Weroha SJ; Zhu WG; Wang YA; DePinho RA; Xu W; Huang H
Cancer Res; 2017 Dec; 77(23):6524-6537. PubMed ID: 28986382
[TBL] [Abstract][Full Text] [Related]
18. KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis.
Wang LY; Hung CL; Chen YR; Yang JC; Wang J; Campbell M; Izumiya Y; Chen HW; Wang WC; Ann DK; Kung HJ
Cell Rep; 2016 Sep; 16(11):3016-3027. PubMed ID: 27626669
[TBL] [Abstract][Full Text] [Related]
19. Wnt receptor Frizzled 8 is a target of ERG in prostate cancer.
Chakravarthi BVSK; Chandrashekar DS; Hodigere Balasubramanya SA; Robinson AD; Carskadon S; Rao U; Gordetsky J; Manne U; Netto GJ; Sudarshan S; Palanisamy N; Varambally S
Prostate; 2018 Dec; 78(16):1311-1320. PubMed ID: 30051493
[TBL] [Abstract][Full Text] [Related]
20. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.
Mallette FA; Richard S
Cell Rep; 2012 Nov; 2(5):1233-43. PubMed ID: 23168260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
